| Literature DB >> 18820730 |
José L Tella1, Jesús A Lemus, Martina Carrete, Guillermo Blanco.
Abstract
BACKGROUND: cological immunology requires techniques to reliably measure immunocompetence in wild vertebrates. The PHA-skin test, involving subcutaneous injection of a mitogen (phytohemagglutinin, PHA) and measurement of subsequent swelling as a surrogate of T-cell mediated immunocompetence, has been the test of choice due to its practicality and ease of use in the field. However, mechanisms involved in local immunological and inflammatory processes provoked by PHA are poorly known, and its use and interpretation as an acquired immune response is currently debated.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18820730 PMCID: PMC2546448 DOI: 10.1371/journal.pone.0003295
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Local tissue swelling (black dots) and body mass (white dots) of 125 birds subjected to two successive PHA-skin tests.
Figure 2Changes in counts of lymphocyte subsets and protein concentrations (μg/L) in the bloodstream from basal levels to those resulting 24 h after a first and a second PHA injection.
Black dots represent experimental birds (injected with PHA) and white dots represent control birds (injected with PBS).
Figure 3Relationships between local tissue swelling induced by first and second PHA injections and the concomitant changes in circulating lymphocyte subsets.
Regression coefficients and statistical significance are shown for each case.
Figure 4Relationships between local tissue swelling induced by first and second PHA injections and the concomitant changes in circulating protein concentrations (μg/L).
Regression coefficient and statistical significance are shown for each case.
Species and number of individuals used for assessing two consecutive responses to PHA injection.
| Species | Body mass (g) | First PHA response (mm) | Second PHA response (mm) | n |
|
| 27.75 | 1.26 | 1.86 | 6 |
|
| 43.83 | 0.35 | 0.88 | 4 |
|
| 44.98 | 0.58 | 0.88 | 2 |
|
| 49.25 | 0.73 | 0.99 | 1 |
|
| 244 | 1.5 | 2.97 | 1 |
|
| 80.19 | 1.26 | 1.76 | 5 |
|
| 123.5 | 1.97 | 2.49 | 2 |
|
| 183 | 1.61 | 2.59 | 2 |
|
| 86.02 | 1.64 | 1.9 | 3 |
|
| 133.75 | 0.45 | 0.9 | 2 |
|
| 28.65 | 0.92 | 1.34 | 1 |
|
| 57.8 | 0.51 | 1.06 | 1 |
|
| 64.45 | 0.45 | 1.3 | 3 |
|
| 28.88 | 0.71 | 1.22 | 2 |
|
| 24.2 | 0.41 | 0.99 | 2 |
|
| 45.3 | 0.24 | 0.79 | 4 |
|
| 107.71 | 1.52 | 2 | 5 |
|
| 137.06 | 1.61 | 2.23 | 6 |
|
| 46.13 | 0.34 | 1.02 | 2 |
|
| 40.85 | 0.22 | 0.68 | 1 |
|
| 42.65 | 0.49 | 1.16 | 2 |
|
| 137.25 | 1.89 | 2.21 | 2 |
|
| 148.25 | 2.07 | 2.63 | 2 |
|
| 98.38 | 0.68 | 1.03 | 4 |
|
| 114 | 0.59 | 1.08 | 1 |
|
| 128.67 | 0.45 | 0.9 | 3 |
|
| 100 | 0.54 | 0.77 | 4 |
|
| 126.17 | 1.54 | 2.11 | 3 |
|
| 165.14 | 0.92 | 1.39 | 7 |
|
| 132.75 | 0.47 | 0.84 | 2 |
|
| 64.94 | 0.41 | 0.87 | 4 |
|
| 130.67 | 1.42 | 2.08 | 9 |
|
| 101.04 | 1.08 | 1.65 | 4 |
|
| 71.18 | 0.93 | 1.81 | 2 |
|
| 75.7 | 1.1 | 1.86 | 3 |
|
| 66.54 | 1.26 | 1.73 | 7 |
|
| 78.08 | 0.78 | 1.31 | 4 |
|
| 72.75 | 1.02 | 1.67 | 5 |
|
| 103.98 | 1.64 | 2.29 | 2 |
Species and number of individuals used to quantify changes in lymphocyte subsets and plasma proteins associated with the primary and secondary responses to PHA injection.
| Species | First response (mm) | Second response (mm) | n | |
| Experimental individuals (injected with PHA) |
| 0.68 | 1.03 | 4 |
|
| 0.59 | 1.08 | 2 | |
|
| 0.54 | 0.77 | 4 | |
|
| 1.06 | 1.60 | 4 | |
|
| 1.30 | 1.89 | 6 | |
| Control individuals (injected with PBS) |
| 0 | 0.04 | 1 |
|
| 0 | 0 | 2 | |
|
| 0.01 | 0.01 | 3 |